B · Normal
[Oriental Bio: Developed high-quality Ebola antigen detection and nucleic acid detection reagents] On September 10th, Oriental Bio stated at the 2026 semi-annual online performance briefing that the company has developed high-quality Ebola antigen detection and nucleic acid detection reagents, and has deployed detection reagents for other insect-borne diseases, and related markets are being expanded. In addition, the company's quantum dot flow fluorescence equipment and reagents have obtained multiple certificates at home and abroad, have been gradually industrialized and entered domestic and foreign markets, and have received good market feedback.
Futures Market Intelligence 🕐 2026-09-10 12:12
#Futures Market Intelligence #Antigen test #Oriental Creatures
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

On September 22, the main domestic SC crude oil futures contract fell 4.24% to 6 09-22 21:15 On September 22, Bank of America raised its Brent crude oil price forecast in th 09-22 21:15 On September 22, CME Group will launch Bitcoin Cash and Uniswap futures to expan 09-22 21:06 On September 22, domestic commodity futures opened with mixed gains in night tra 09-22 21:00 September 22 (Xinhua) U.S. Secretary of State Rubio said that the rise in oil pr 09-22 19:44 On September 22, US Secretary of State Rubio stated that 60% to 70% of the oil f 09-22 19:14

Comments

0/500
Captcha (click to refresh)
No comments yet